Gregor Novak
University of Ljubljana(SI)Ljubljana University Medical Centre(SI)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Immunodeficiency and Autoimmune Disorders, Biosimilars and Bioanalytical Methods, Celiac Disease Research and Management
Most-Cited Works
- → Histologic scoring indices for evaluation of disease activity in Crohn’s disease(2017)124 cited
- → Review article: dose optimisation of infliximab for acute severe ulcerative colitis(2017)92 cited
- → The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?(2017)86 cited
- → Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission(2020)51 cited
- → Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease(2017)51 cited
- → Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview(2017)48 cited
- → Success and safety of high infliximab trough levels in inflammatory bowel disease(2018)46 cited
- → Natural History and Risk Stratification of Recurrent Crohn’s Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study(2021)42 cited
- → Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease(2019)40 cited
- → The safety of vedolizumab for the treatment of ulcerative colitis(2017)40 cited